Latest:
Copay Assistance Programs for Adalimumab Biosimilars
© 2024 MJH Life Sciences™ and Center for Biosimilars®. All rights reserved.
Latest:
Opinion: The Inflation Reduction Act is a Step Backward for Biosimilar Competition
Latest:
Opinion: The Legal and Regulatory Year in Review
Latest:
Contributor: Self-Administered Biosimilars Are Coming Quickly—Is Your Clinic Ready?
Latest:
Why Are Companies Launching Biosimilars With 2 Prices? Julie Reed Explains
Latest:
The Growth of Biosimilars Continues to Create Hope for Lower Drug Costs
Latest:
Legal Opinion: BPCIA Is Likely to Survive Latest ACA Challenge
Latest:
Common Patient Questions About Insulin Biosimilars Pertain to Classification